Berger Dietmar has filed 12 insider transactions across 1 company since January 2025.
Most recent transaction: a option exercise of 2133 shares of GILEAD SCIENCES, INC. ($GILD) on March 10, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 10, 2026 | GILEAD SCIENCES, INC. | $GILD | Berger Dietmar | Chief Medical Officer | M | Common Stock | 2133 | $0.00 | 20,045.0000 | 1,256,000,000 | 11.91% | 0.00% |
| March 10, 2026 | GILEAD SCIENCES, INC. | $GILD | Berger Dietmar | Chief Medical Officer | A | Non-qualified Stock Option (Right to Buy) | 31475 | $0.00 | 31,475.0000 | 1,256,000,000 | 9999.99% | 0.00% |
| March 10, 2026 | GILEAD SCIENCES, INC. | $GILD | Berger Dietmar | Chief Medical Officer | A | Restricted Stock Unit | 8415 | $0.00 | 47,461.0000 | 1,256,000,000 | 21.55% | 0.00% |
| March 10, 2026 | GILEAD SCIENCES, INC. | $GILD | Berger Dietmar | Chief Medical Officer | M | Restricted Stock Unit | 2133 | $0.00 | 39,046.0000 | 1,256,000,000 | 5.18% | 0.00% |
| March 10, 2026 | GILEAD SCIENCES, INC. | $GILD | Berger Dietmar | Chief Medical Officer | F | Common Stock | 1063 | $148.56 | 18,982.0000 | 1,256,000,000 | 5.30% | 0.00% |
| Feb. 27, 2026 | GILEAD SCIENCES, INC. | $GILD | Berger Dietmar | Chief Medical Officer | A | Common Stock | 8530 | $0.00 | 17,912.0000 | 1,256,000,000 | 90.92% | 0.00% |
| Jan. 2, 2026 | GILEAD SCIENCES, INC. | $GILD | Berger Dietmar | Chief Medical Officer | M | Restricted Stock Unit | 16326 | $0.00 | 41,179.0000 | 1,256,000,000 | 28.39% | 0.00% |
| Jan. 2, 2026 | GILEAD SCIENCES, INC. | $GILD | Berger Dietmar | Chief Medical Officer | F | Common Stock | 6944 | $121.60 | 9,382.0000 | 1,256,000,000 | 42.53% | 0.00% |
| Jan. 2, 2026 | GILEAD SCIENCES, INC. | $GILD | Berger Dietmar | Chief Medical Officer | M | Common Stock | 16326 | $0.00 | 16,326.0000 | 1,256,000,000 | 9999.99% | 0.00% |
| March 10, 2025 | GILEAD SCIENCES, INC. | $GILD | Berger Dietmar | Chief Medical Officer | A | Restricted Stock Unit | 8530 | $0.00 | 57,505.0000 | 1,255,000,000 | 17.42% | 0.00% |
| March 10, 2025 | GILEAD SCIENCES, INC. | $GILD | Berger Dietmar | Chief Medical Officer | A | Non-qualified Stock Option (Right to Buy) | 37710 | $0.00 | 37,710.0000 | 1,255,000,000 | 9999.99% | 0.00% |
| Jan. 2, 2025 | GILEAD SCIENCES, INC. | $GILD | Berger Dietmar | Chief Medical Officer | A | Restricted Stock Unit | 48975 | $0.00 | 48,975.0000 | 1,255,000,000 | 9999.99% | 0.00% |